U.S. clinicians should consider cholera in patients with acute diarrhea returning from countries with cholera transmission, the Centers for Disease Control and Prevention said in an advisory yesterday, citing eight cases this year in travelers returning to the United States. The advisory includes recommendations to help clinicians, pharmacies and laboratories identify, test and treat suspected cases.

“Although cholera in travelers is rare and sustained community transmission in the United States is unlikely, widespread cholera outbreaks in other countries highlight the need for clinicians in the United States to be prepared to treat travelers with cholera, as they could arrive in the United States at any time,” the advisory notes.

Related News Articles

Headline
The AHA Sept. 25 launched its 2023-24 United Against the Flu campaign to help hospitals and health systems encourage their communities to get vaccinated for…
Headline
This season’s flu vaccines for the Southern Hemisphere have reduced the risk of being hospitalized for flu by 52%, based on mid-season data from five countries…
Headline
The Centers for Disease Control and Prevention alerted clinicians, laboratories and public health departments to recent fatal infections from Vibrio…
Headline
The Food and Drug Administration announced its approval of Pfizer’s Abrysvo (Respiratory Syncytial Virus Vaccine), the first vaccine approved for use…
Chairperson's File
It’s been about 65 years since an effective vaccine was first used worldwide against poliomyelitis, or polio. Until then, polio was responsible for about 500,…
Headline
AHA this week released a resource on strategies and tactics that hospitals and health systems can adopt to prevent and control health care-associated…